The Nifty Pharma index closed 0.01 per cent up at 12457.85.

Hindalco, JSW Steel, Adani Ports SEZ, UPL and Coal India Ltd were among the top losers on NSE.

The Nifty Pharma index was trading 0.04 per cent down at 12451.9.

Apollo Hospital, Hero MotoCorp, M&M, Tech Mahindra and UltraTech Cem. were among the top losers on NSE.

The Nifty Pharma index was trading 0.21 per cent down at 12428.25.

Nifty Midcap outperformed its headline peers and advanced 1.22 per cent.

The US is still relying on Indian firms to import HCQ even after the drug fell out of favor as a Covid treatment.

On Mar 21, two days after President Trump first touted chloroquine drugs as a "gamechanger" in the fight against COVID-19, administration o...

Cadila has 32 per cent market share in API hydroxychloroquine in the US.

IPCA has a market share of nearly 70% of these drugs, as it is one of the largest suppliers of the active pharmaceutical ingredient of thes...

In all the cases, the "abduction" is by their spouses, who fled to India after marital dispute and got court orders against them.

Diwan believes that Ipca Labs is at the cusp of a turnaround. He likes Ranbaxy, Cipla and Dr Reddy’s Labs among the largecap names.

While there has been no resolution of the FDA issues, four products have been exempted from the import ban, in two of which Ipca enjoys hig...

'There will be some corrections coming in, but more or less, the markets are headed for newer tops from here on,' says Rahul Shah.

Tata Group Chairman Cyrus Mistry informed Chouhan about the expansion plans of the Dewas-based Tata International, it said.

IPCA LABS: The company will hold a board meeting to consider the allotment of equity shares on exercise of options under the company’s 2006...

Mumbai-based mid-size pharma company Ipca Laboratories along with Makers Laboratories has picked up additional stake in bulk drugs and chem...